Streptococcus pyogenes (group A streptococcus [GAS]) causes a spectrum of infections, which range from pharyngitis and impetigo to more-invasive life-threatening diseases, such as necrotizing fasciitis and toxic-shock syndrome [1] . Lethal S. pyogenes soft-tissue infections are associated with a paucity of neutrophils at the site of infection [2] [3] [4] . The S. pyogenes cell envelope proteinase SpyCEP can cleave and inactivate human interleukin (IL)-8 at Glu59-Arg60, removing the IL-8 Cterminal a-helix and thereby interrupting one of the
fundamental human mechanisms of protective phagocyte recruitment [3] .
SpyCEP is a cell wall-anchored subtilisin-like serine protease that can be released as a soluble enzyme [3, 5, 6] ; although structurally similar to streptococcal C5a peptidases, it has no proteolytic activity against the C5a component of complement [3] . Invasive blood isolates of S. pyogenes have high SpyCEP activity, whereas lower activity is seen in noninvasive pharyngeal isolates [3] . In the present study, we explored the basis for variation in SpyCEP expression between invasive and noninvasive isolates. In this article, we demonstrate that such variation is regulated at the level of transcription of the SpyCEP gene cepA (also known as "scpC") and that disease severity is associated with SpyCEP activity among invasive isolates. We confirm that cepA is subject to repression by the 2-component control of virulence regulatory sensor CovR/S in pharyngeal strains that demonstrate low SpyCEP activity [7] . In contrast, strains with the greatest SpyCEP activity may have mutations within CovR/S. In this article, we show that a mutation in the covR locus underlies the extremely high expression of SpyCEP and the associated virulence of one lethal invasive isolate, and we highlight the poten- Table 2 .
Primers Used in This Study
The table is available in its entirety in the online edition of the Journal of Infectious Diseases tial for harmful mutations to spread within the community.
MATERIALS AND METHODS
Bacterial strains and media. Invasive S. pyogenes isolates ( ) were obtained from blood or muscle culture specin p 17 mens from patients who, from 1994 through 2005, were referred to the infectious disease service at Hammersmith Hospital (London, United Kingdom) with a range of invasive disease manifestations, including necrotizing fasciitis and pneumonia. Invasive isolate H292 was recovered from a patient with bacteremia and lethal necrotizing fasciitis [3] . For measurement of gene expression, we used 9 invasive isolates that were included in a previously published report [3] , although all activity analyses were repeated for the present study. Noninvasive isolates ( ) were obtained from patients with uncomplicated n p 8 pharyngitis. Strain H305, an M1 scarlet fever throat strain (NCTC 8198), was included as a well-characterized reference isolate [8] . For covR/S sequence analysis, isolates from a 1930-1940 S. pyogenes collection, as well as additional emm1 and emm81 blood culture isolates recovered in the United Kingdom, were also included.
S. pyogenes was grown in Todd-Hewitt broth (Oxoid) or Columbia horse blood agar. Escherichia coli strains were cultured in Luria-Bertani broth (Oxoid). Antibiotics were used at the following concentrations: 1 mg/mL erythromycin and 50 mg/mL kanamycin.
Patient serum samples. Serum samples were obtained from 15 patients at the time of admission to the hospital and before antibiotics were administered; these patients were subsequently proven to have invasive S. pyogenes infection (5 had necrotizing fasciitis, 2 had pneumonia, 3 had cellulitis, and 5 had other types of infection) (table 1, which appears only in the electronic version of the Journal). Clotted blood samples were drawn at admission to the hospital for clinical chemical analysis, and residual serum samples were stored frozen at Ϫ80ЊC for research purposes. Serum samples were associated with the causal S. pyogenes isolates.
Enzyme-linked immunosorbent assay. Human IL-6 was measured in patient serum samples by means of the enzymelinked immunosorbent assay (ELISA) development kit DuoSet (R&D). IL-8 cleaving activity was measured in the late-log (LL)-phase (optical density measured at 600 nm [OD 600 ], 0.7-0.9) culture bacterial cell-free supernatant coincubated at 37ЊC overnight with 5 ng/mL human IL-8 (R&D) and either 50% normal ("nonimmunized") rabbit serum or anti-SpyCEP rabbit serum raised against a recombinant protein representing residues 35-587 of the pre-pro SpyCEP sequence (ie, including signal sequence; GenBank accession no. DQ413032) [6] . Uncleaved IL-8 was measured using human IL-8 DuoSet ELISA (R&D) (which does not detect cleaved IL-8), and IL-8 cleaving activity caused by SpyCEP was calculated in comparison to the control (IL-8 in Todd-Hewitt broth).
Gene sequence analysis. Bacterial DNA was extracted using the method of Pospiech and Neumann [9] . The primers used in the present study (table 2, which appears only in the electronic version of the Journal) were designed using the available GenBank S. pyogenes genomes. Automated fluorescent DNA sequencing was provided by the Genomics Core Laboratory, Medical Research Council Clinical Sciences Centre, Hammersmith Hospital. emm typing was performed according to the protocol of the Centers for Disease Control and Prevention [10] . CovR/S mutations were assigned as nonsynonymous variations that were not present in all the available S. pyogenes genome sequences.
Quantitative real-time polymerase chain reaction. RNA was extracted from early-log (EL; OD 600 , 0.2-0.3), midlog (ML; OD 600 , 0.5), and late-log (LL; OD 600 , 0.7-0.9) phases of growth, on 3 separate occasions (supplemental methods are described in the appendix, which appears only in the electronic version of the Journal). Complementary DNA was synthesized from 5 mg of Turbo DNA-free (Ambion)-treated RNA (Transcriptor Reverse Transcriptase; Roche Diagnostics). Real-time polymerase chain reaction (PCR) was performed on 200 ng of complementary DNA template in triplicate, by use of SYBR Green JumpStart Taq ReadyMix (Sigma). A standard-curve method was applied to calculate the copy number for each transcript by use of the BamH1 linearized plasmid (RTpCR2.1) of known concentration ( to copies). RTpCR2.1 was con-8 2 2 ϫ 10 2 ϫ 10 structed using the TA Cloning Kit (Invitrogen), to contain single copies of blunt-end ligated 100-to 150-bp regions of cepA and hasA, and reference gene gyrA, which was generated by PCR (table 2, which appears only in the electronic version of the Journal). Each standard reaction also contained 5 ng of l DNA to stabilize the plasmid and mimic amplification conditions of the sample reactions. Copies of sample transcript were measured against the standard and were normalized to 10,000 copies of gyrA.
Construction of CovR/S mutant pharyngeal GAS strains. A 39-to 377-bp region of the covR coding sequence that was amplified using CovR-knockout (KO) primers (table 2, which appears only in the electronic version of the Journal) was cloned into the EcoRI site of the temperature-sensitive shuttle vector pGhostaph1 [11] . The plasmid, which was designated "pGhostcovR," was used to transform 2 pharyngeal S. pyogenes isolates (emm75 and emm2) by electroporation. Transformants were selected using erythromycin at 30ЊC and then were moved to 37ЊC in liquid culture to obtain plasmid integration. Transformants were analyzed by PCR and Southern blot hybridization.
Western blot analysis of culture supernatant and cell wall fractions. Supernatant and cell pellets were obtained from isolates cultured to the EL, ML, and LL phases of growth. Cell wall preparations were made using an enzymatic method described elsewhere by Biswas et al [12] . Proteins were separated by use of 10% Bis-Tris sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels (Invitrogen) and underwent immunoblotting performed using rabbit polyclonal antiSpyCEP serum. Blots were developed using the ECL system (GE Healthcare).
IL-8 cleavage SDS-PAGE and immunoblotting.
Cell-free bacterial culture supernatant was incubated at 37ЊC overnight with 100 mg/mL human IL-8 (R&D). IL-8 was detected using 12% Bis-Tris SDS-PAGE (Invitrogen) stained with Colloidal Blue Staining Kit (Invitrogen) or immunoblotted using antihuman IL-8 horseradish peroxidase-labeled antibody (R&D) and streptavidin (R&D).
Electromobility shift assay. Wild-type CovR (from reference strain H305) and mutant CovR (from strain H292) were expressed and purified from E. coli (see the appendix, which appears only in the electronic version of the Journal). Electromobility shift assay primers (see table 1 , which appears only in the electronic version of the Journal) yielded 295-bp and 336-bp products for the cepA and hasA promoter regions, respectively, and were labeled with digoxigenin (DIG) by use of the Nonradioactive Gel Mobility Shift Assay Kit (Roche Diagnostics). CovR protein was diluted in binding buffer (50 mmol/L potassium chloride, 25 mmol/L Tris [pH 8], 5 mmol/ L magnesium chloride, 3 mmol/L calcium chloride, 4% glycerol, 1 mg/mL bovine serum albumin, 10 mg/mL salmon sperm DNA, 0.5 mmol/L ethylenediaminetetraacetic acid [EDTA], and 0.5 mmol/L dithiothreitol) [13] with 0.8 ng of labeled promoter and incubated at room temperature for 20 min before it was loaded onto a 0.5 ϫ Tris-borate-EDTA DNA retardation gel (Invitrogen). DNA was electrotransferred onto Hybond-N (GE Healthcare) membrane, and DIG-labeled DNA was detected using anti-DIG alkaline phosphatase antibody and developed with CDP-Star (Roche Diagnostics).
Ethics. The collection, storage, and testing of anonymized serum samples and bacterial strains obtained from patients identified as having invasive S. pyogenes infection were approved by the local research ethics committee of the Hammersmith Hospitals National Health Service Trust.
Statistical analysis. All statistics analyses were performed using nonparametric analysis with GraphPad Prism software for Windows (version 4.03; GraphPad Software).
RESULTS

SpyCEP-dependent IL-8 cleaving activity in clinical isolates.
IL-8 cleaving activity was tested in a range of clinical isolates, both invasive ( ) and noninvasive ( ) and of difn p 15 n p 8 ferent emm types (figure 1). Consistent with the findings of a previously published report [3] , invasive isolates had greater IL-8 cleaving activity (86.0%; range, 54.3%-93.6%) than did noninvasive isolates (60.7%; range, 23.5%-87.3%) (
). P ! .011 IL-8 cleaving activity was specifically caused by proteolytic activity of SpyCEP, because IL-8 cleavage was abrogated by coincubation with specific anti-SpyCEP antibody.
Variation in IL-8 cleaving activity and cepA transcription. Sequence analysis of the SpyCEP gene cepA in S. pyogenes isolates of different emm types (8 invasive, 8 noninvasive, and 1 reference strain) showed that variation in IL-8 cleaving activity was not associated with an alteration in cepA sequence (GenBank accession nos. DQ413032-DQ413046, EU730694, and EU730695).
SpyCEP was expressed continuously throughout exponential growth both in supernatant and in the cell wall (data not shown). Separate ELISA studies performed on whole cells confirmed that cell wall SpyCEP was biologically active (not shown).
Expression of cepA at ML phase was highly variable between isolates, ranging from 10 to 10,000 copies of cepA per 10,000 copies of the housekeeping gene gyrA (figure 2A). Invasive isolates ( ) expressed levels of cepA that were higher than n p 9 those expressed by noninvasive isolates ( ) ( , n p 8 P p .046 Mann-Whitney U test). Expression of capsule operon member hasA was also increased in invasive isolates, compared with noninvasive isolates, and it correlated positively with cepA expression (figure 2B) ( , Spearman rank correlation; r p 0.67 ), suggesting that both genes were coregulated. hasA P ! .003 is known to be negatively controlled by the 2-component system CovR/S [14, 15] . This finding is consistent with 2 putative ATTARA CovR-binding sites located within the cepA promoter region, which were present in all isolates sequenced (GenBank accession nos. DQ413032-DQ412047, EU730694, and EU730695).
Pharyngeal isolates and experimental increases in enhanced IL-8 cleaving activity through mutation of covR/S. We hypothesized that if CovR/S represses SpyCEP expression in noninvasive pharyngeal isolates, then disruption of the covR/S locus in these isolates would de-repress cepA. Mutagenesis of covR/ S in an emm75-type low SpyCEP-producing pharyngeal isolate resulted in a mutant covR/S strain (DcovR/S). Western blot analysis demonstrated that, although SpyCEP was undetectable in the parent strain, it was clearly present both in the super- natant and in the cell wall of DcovR/S ( figure 3A ). This finding was associated with clear acquisition of IL-8 cleaving activity in the culture supernatant of DcovR/S, which was absent in the culture supernatant of the parent strain ( figure 3B ). Real-time PCR analysis confirmed an ∼200-fold increase in cepA expression in the EL and ML phases and a 10-fold increase in the LL phase ( figure 3C ). To verify that this increase was not an emmtype-specific phenomenon, covR/S mutagenesis was repeated in another low SpyCEP-producing pharyngeal isolate of a different emm type: emm2. Similar increased expression of SpyCEP was seen with 200-, 100-, and 10-fold increases in the EL, ML, and LL phases, respectively. The data confirmed that CovR/S represses cepA in noninvasive isolates and that repression is more pronounced in the EL to ML phases of logarithmic growth. Association of SpyCEP activity in invasive disease with severity of disease. Focusing on invasive disease isolates, bacterial SpyCEP activity was determined for each of 15 clinical cases of disease for which paired serum samples and isolates were available; 14 of 15 patients had bacteremia. Although numbers were small, nonsurvivors yielded isolates that had higher IL-8 cleaving activity (median, 92.1%; range, 89.8%-93.60%) than did those from survivors (median, 77.0%; range, 54.3%-91.3%) ( ) ( figure 4A ). Consistent with this find-P ! .016 ing, isolates with the greatest SpyCEP activity (190%) were associated with the highest serum IL-6 levels in patients (figure 4B) .
Invasive isolates and acquisition of marked IL-8 cleaving activity through natural mutation of covR. In recent years, emm81 strains have emerged as important causes of invasive GAS disease in Europe [16] [17] [18] [19] . Of the 6 invasive emm81 isolates studied, strain H292 was the only isolate to cause lethal disease with rapidly progressive lethal necrotizing fasciitis. H292 expressed more cepA than any other isolate analyzed. To confirm that high cepA expression was unique to strain H292, we compared the expression of SpyCEP in 5 contemporaneous clinical emm81 isolates recovered from patients with nonfatal cases of invasive disease. Strain H292 expressed approximately 20-to 800-fold, 20-to 3000-fold, and 2-to 400-fold more copies of cepA than did the other 5 emm81 isolates (a-e), during the EL, ML, and LL phases, respectively (figure 5A). Transcription of hasA in these isolates was consistent with cepA; H292 expressed 160-fold more copies of hasA than did all the 5 other emm81 isolates (figure 5B). Taken together, the results suggest that enhanced disease severity can be associated with specific and detectable polarization of phenotype.
We hypothesized that CovR/S mutations may be responsible for the high expression of cepA in strain H292; therefore, we sequenced the covR/S locus in this isolate and 5 other emm81 isolates. Although other emm81 isolates were wild type for CovR/S, strain H292 had a substitution mutation in CovR of alanine (Ala) to valine (Val) at amino acid (aa) residue 111 (table 3) . This mutation was stable despite passage in vitro and in vivo.
Electromobility shift assays were performed to examine binding of recombinantly expressed CovR protein from the reference strain or strain H292 to a 295-bp region of the cepA promoter (pcepA). Without phosphorylation, dose-dependent binding of CovR occurred, shifting the CovR-pcepA complex to form I (figure 6A). On phosphorylation, the CovR-pcepA complex further shifted to form II, confirming binding of CovR directly to the cepA promoter. Without phosphorylation, mutant H292-CovR demonstrated binding similar to that demonstrated by the wild type; in contrast, with phosphorylation, the mutant H292-CovR was unable to shift the complex further to form II. Binding to the has operon promoter was similarly affected by the single-residue substitution (figure 6B), confirming that the mutation in CovR impaired its phosphorylationenhanced ability to bind to both the SpyCEP and capsule operon promoters.
Commonality of variations in CovS but not CovR among isolates of different emm types and evidence of spread in the community. CovS mutations have recently been highlighted to underlie the invasiveness of modern emm1 isolates [20, 21] . Sequencing of covR/S in a broadened range of clinical isolates of various emm types obtained from 2 collections of isolates at Hammersmith Hospital revealed a number of variations in covS but not covR (tables 3 and 4, the latter of which appears only in the electronic version of the Journal). In contrast to the covR mutation seen in strain H292, CovS single-amino acid changes Isolates were matched to the disease outcome of the patient from which they originated (survivors or nonsurvivors). The median value of the data is denoted by a horizontal line. SpyCEP activity was significantly higher in strains from nonsurvivors ( , Mann-Whitney U test). B, Association of patient serum IL-6 levels with the SpyCEP activity of P ! .016 the causative isolate. IL-6 was measured by ELISA performed on patient serum samples obtained at the onset of bacteremia. High IL-6 levels were associated with high SpyCEP activity apparent at SpyCEP activity 190% (dotted line). were found in both invasive and noninvasive isolates and were not necessarily associated with high expression of cepA. Reference emm1 strain H305, a scarlet fever throat isolate (NCTC 8198) and a high expresser of cepA, had a single-base insert mutation in covS that results in a premature stop codon. A single consistent variation (I 332 to V 332 ) was observed in modern emm1 isolates originating from patients in West London in 1999-2000, in some cases coupled with an additional variation (Ala to threonine [Thr] at aa 38); this variation was observed in both blood and throat isolates.
DISCUSSION
S. pyogenes cell envelope proteinase SpyCEP cleaves and inactivates IL-8 and other CXC chemokines, disrupting IL-8-mediated neutrophil recruitment [3, 6, 7, 22] . In the present study, all clinical isolates tested were able to cleave IL-8 to some degree, and this activity could be specifically prevented by SpyCEP-targeted antiserum, confirming that SpyCEP is responsible for IL-8 cleaving activity in all GAS strains. Consistent with a previous report by Edwards et al [3] , SpyCEP activity was higher in clinical invasive isolates than in noninvasive isolates, regardless of emm type.
In the present study, we had a unique opportunity to measure serum cytokine levels and bacterial SpyCEP activity in samples obtained from the same patients at the time of admission to the hospital. S. pyogenes SpyCEP activity was associated with a poor outcome and elevated levels of serum IL-6, suggesting that SpyCEP plays an important role in determining the severity of human disease. This finding is consistent with the findings of Zinkernagal et al [6] and Hidalgo-Grass et al [22] , who demonstrated that mutagenesis of cepA (or scpC) led to attenuation of infection severity in mouse models. Elevated IL-6 levels have been associated with severe sepsis, toxic-shock syndrome, and poor disease outcome [23] [24] [25] [26] [27] . In the present study, high serum levels of IL-6 at the time of bacteremia were associated with failure to survive; patients who survived (n p ) had lower IL-6 levels (median, 1.9 ng/mL; range, 0.13-159 11 ng/mL) than did patients who did not survive ( ) (median, n p 4 215 ng/mL; range, 2.7-400 ng/mL) ( ). Interestingly, P ! .022 serum IL-8 levels did not correlate inversely with SpyCEP activity. We speculate that, during sepsis, serum IL-8 levels may reflect the severity of the disease and substrate abundance rather than SpyCEP abundance. It is also possible that serum IL-8 levels may not reflect tissue levels of IL-8, as supported by findings in mouse models [22] .
SpyCEP is part of a family of lactococcal and streptococcal serine proteases that have adapted to cleave host chemokines; in addition to the C5a peptidases, homologues exist in many other pathogenic streptococci, including Streptococcus agalactiae (CspA), Streptococcus pneumoniae (PrtA), Streptococcus equi (SeCEP), and Streptococcus iniae (CepI) [6, 22, 28, 29] . In the present study, sequence analysis of different emm types showed the SpyCEP gene (cepA) to be highly conserved and unlikely to underlie the observed variation in SpyCEP activity between invasive and noninvasive isolates. Recently, invasive M1 S. pyogenes isolates were reported to demonstrate distinct transcriptomes, compared with noninvasive isolates [20] ; up-regulation of virulence factors, including SpyCEP, was attributed to mutations in the sensory component of the 2-component gene regulator system CovR/S. CovR/S represses ∼15% of the genome [30, 31] , including hasA, a component of the hyaluronic acid capsule operon [15] . In the present study, expression of hasA correlated positively with cepA expression, suggesting that both genes are under the same regulatory influence. Deletion of the covR/S locus up-regulated cepA and conferred IL-8-degrading activity on 2 non-IL-8-degrading pharyngeal isolates, thus demonstrating that cepA is under the negative influence of CovR/S, even in non-emm1 strains. Expression of cepA was growth phase dependent, and, unlike other cell wall proteins, increased toward late logarithmic growth.
Strain H292 is an invasive emm81 isolate obtained from the blood of a patient who rapidly died of necrotizing fasciitis [3] . emm81 strains are increasingly recognized in Europe and represented 10%-20% of invasive isolates in the United Kingdom and Sweden [16] [17] [18] [19] . Strain H292 had very high SpyCEP activity and expressed the highest cepA transcript copy number, compared with the other isolates tested, including other emm81 isolates. The high expression of cepA was attributed to a mutation within covR comprising a single-amino acid change of alanine to valine at aa 111; the in vivo effect of this CovR mutation could be further investigated by gene replacement of CovR. Nonetheless, the in vitro studies reported herein demonstrate that this mutation affects phosphorylation-dependent binding of CovR not only to the cepA promoter but also to the hasA promoter. Wild-type CovR demonstrated binding to the cepA promoter, consistent with the recently published findings of Sumby et al [7] . Mutant H292-CovR was unable to shift to form II upon phosphorylation, indicating reduced and/ or unstable binding of CovR to the cepA and hasA promoters. This finding suggests that the variant H292-CovR would lead to reduced repression of target promoters [13] . Whether the H292-CovR mutation altered CovS-mediated phosphorylation directly or whether it interfered with phosphorylation-dependent dimerization of CovR is unknown. Interestingly, the mutation in H292-CovR is in a region that is highly conserved amongst response regulators from other bacterial species but is not a recognized region for phosphorylation [32] .
It was recently proposed that CovS mutations resulting in invasive GAS arose solely through selective pressure from a novel DNAse present in modern M1 strains only [20, 21] . Although mutations that impede the function of CovS may contribute to virulence, our data show that some CovS sequence variations were observed both in invasive isolates and in noninvasive isolates, without any measurable effect on cepA expression. This may either be because the amino acid changes do not impede kinase activity or, perhaps, because CovS mutations can only have an indirect effect on CovR; CovR may be phosphorylated through other as-yet-undefined mechanisms. Many of the observed differences in CovS may reflect allelic variants that do not alter function.
Reference emm1 strain H305, a scarlet fever isolate dating from the 1880s, had a mutation in covS that resulted in a premature stop codon. This finding potentially explains the high expression of exotoxins cepA and hasA by this isolate and confirms that selective pressure for mutations in covR/S is not associated with modern strains alone.
Other CovR mutations were not found in our small collection of strains, although a CovR mutation in an emm3 isolate has previously been reported to affect capsule expression [33] . In the present article, we have shown that CovR mutations can exert stable and dramatic effects on virulence factor expression but that these mutations are rare. Reduced fitness to spread may be the reason behind the rarity of CovR mutations. CovR/ S impaired-function mutations potentially select against the carriage/pharyngeal state; whether major CovR/S mutations can confer or impede fitness to spread within a population now deserves focussed consideration, as does the possibility that such mutations might explain rare clusters of invasive S. pyogenes disease [34] .
